Filtered By:
Source: Allergy, Asthma and Immunology Research
Condition: Hives

This page shows you your search results in order of date.

Order by Relevance | Date

Total 701 results found since Jan 2013.

Efficacy of Second-Line Treatments in Chronic Urticaria Refractory to Standard Dose Antihistamines
CONCLUSIONS: In patients with CU refractory to standard doses of nsAHs, both updosing of nsAHs 4-fold and multiple combination treatment with 4 nsAHs increased the rate of well-controlled cases without causing significant adverse effects. Updosing of nsAHs is more effective for complete CU control than combination treatment.PMID:37153977
Source: Allergy, Asthma and Immunology Research - May 8, 2023 Category: Allergy & Immunology Authors: Mi-Ae Kim Jeong-Hee Choi Yoo-Seob Shin Hae-Sim Park Young-Min Ye KAAACI Work Group on Urticaria/Angioedema/Anaphylaxis Source Type: research

A Case Series of Chronic Spontaneous Urticaria After COVID-19 Vaccination
Allergy Asthma Immunol Res. 2023 Jan 26. Online ahead of print.NO ABSTRACTPMID:37153976
Source: Allergy, Asthma and Immunology Research - May 8, 2023 Category: Allergy & Immunology Authors: Jeong-Hee Choi Soo Jie Chung Source Type: research

Efficacy of Second-Line Treatments in Chronic Urticaria Refractory to Standard Dose Antihistamines
CONCLUSIONS: In patients with CU refractory to standard doses of nsAHs, both updosing of nsAHs 4-fold and multiple combination treatment with 4 nsAHs increased the rate of well-controlled cases without causing significant adverse effects. Updosing of nsAHs is more effective for complete CU control than combination treatment.PMID:37153977
Source: Allergy, Asthma and Immunology Research - May 8, 2023 Category: Allergy & Immunology Authors: Mi-Ae Kim Jeong-Hee Choi Yoo-Seob Shin Hae-Sim Park Young-Min Ye KAAACI Work Group on Urticaria/Angioedema/Anaphylaxis Source Type: research

A Case Series of Chronic Spontaneous Urticaria After COVID-19 Vaccination
Allergy Asthma Immunol Res. 2023 Jan 26. Online ahead of print.NO ABSTRACTPMID:37153976
Source: Allergy, Asthma and Immunology Research - May 8, 2023 Category: Allergy & Immunology Authors: Jeong-Hee Choi Soo Jie Chung Source Type: research

Efficacy of Second-Line Treatments in Chronic Urticaria Refractory to Standard Dose Antihistamines
CONCLUSIONS: In patients with CU refractory to standard doses of nsAHs, both updosing of nsAHs 4-fold and multiple combination treatment with 4 nsAHs increased the rate of well-controlled cases without causing significant adverse effects. Updosing of nsAHs is more effective for complete CU control than combination treatment.PMID:37153977
Source: Allergy, Asthma and Immunology Research - May 8, 2023 Category: Allergy & Immunology Authors: Mi-Ae Kim Jeong-Hee Choi Yoo-Seob Shin Hae-Sim Park Young-Min Ye KAAACI Work Group on Urticaria/Angioedema/Anaphylaxis Source Type: research

A Case Series of Chronic Spontaneous Urticaria After COVID-19 Vaccination
Allergy Asthma Immunol Res. 2023 Jan 26. Online ahead of print.NO ABSTRACTPMID:37153976
Source: Allergy, Asthma and Immunology Research - May 8, 2023 Category: Allergy & Immunology Authors: Jeong-Hee Choi Soo Jie Chung Source Type: research

Efficacy of Second-Line Treatments in Chronic Urticaria Refractory to Standard Dose Antihistamines
CONCLUSIONS: In patients with CU refractory to standard doses of nsAHs, both updosing of nsAHs 4-fold and multiple combination treatment with 4 nsAHs increased the rate of well-controlled cases without causing significant adverse effects. Updosing of nsAHs is more effective for complete CU control than combination treatment.PMID:37153977
Source: Allergy, Asthma and Immunology Research - May 8, 2023 Category: Allergy & Immunology Authors: Mi-Ae Kim Jeong-Hee Choi Yoo-Seob Shin Hae-Sim Park Young-Min Ye KAAACI Work Group on Urticaria/Angioedema/Anaphylaxis Source Type: research

A Case Series of Chronic Spontaneous Urticaria After COVID-19 Vaccination
Allergy Asthma Immunol Res. 2023 Jan 26. Online ahead of print.NO ABSTRACTPMID:37153976
Source: Allergy, Asthma and Immunology Research - May 8, 2023 Category: Allergy & Immunology Authors: Jeong-Hee Choi Soo Jie Chung Source Type: research

Efficacy of Second-Line Treatments in Chronic Urticaria Refractory to Standard Dose Antihistamines
CONCLUSIONS: In patients with CU refractory to standard doses of nsAHs, both updosing of nsAHs 4-fold and multiple combination treatment with 4 nsAHs increased the rate of well-controlled cases without causing significant adverse effects. Updosing of nsAHs is more effective for complete CU control than combination treatment.PMID:37153977
Source: Allergy, Asthma and Immunology Research - May 8, 2023 Category: Allergy & Immunology Authors: Mi-Ae Kim Jeong-Hee Choi Yoo-Seob Shin Hae-Sim Park Young-Min Ye KAAACI Work Group on Urticaria/Angioedema/Anaphylaxis Source Type: research

A Case Series of Chronic Spontaneous Urticaria After COVID-19 Vaccination
Allergy Asthma Immunol Res. 2023 Jan 26. Online ahead of print.NO ABSTRACTPMID:37153976
Source: Allergy, Asthma and Immunology Research - May 8, 2023 Category: Allergy & Immunology Authors: Jeong-Hee Choi Soo Jie Chung Source Type: research

Efficacy of Second-Line Treatments in Chronic Urticaria Refractory to Standard Dose Antihistamines
CONCLUSIONS: In patients with CU refractory to standard doses of nsAHs, both updosing of nsAHs 4-fold and multiple combination treatment with 4 nsAHs increased the rate of well-controlled cases without causing significant adverse effects. Updosing of nsAHs is more effective for complete CU control than combination treatment.PMID:37153977
Source: Allergy, Asthma and Immunology Research - May 8, 2023 Category: Allergy & Immunology Authors: Mi-Ae Kim Jeong-Hee Choi Yoo-Seob Shin Hae-Sim Park Young-Min Ye KAAACI Work Group on Urticaria/Angioedema/Anaphylaxis Source Type: research

A Case Series of Chronic Spontaneous Urticaria After COVID-19 Vaccination
Allergy Asthma Immunol Res. 2023 Jan 26. Online ahead of print.NO ABSTRACTPMID:37153976
Source: Allergy, Asthma and Immunology Research - May 8, 2023 Category: Allergy & Immunology Authors: Jeong-Hee Choi Soo Jie Chung Source Type: research

Clavulanic Acid Is a Leading Culprit Beta-Lactam in Immediate Allergic Reactions to Penicillins
CONCLUSIONS: Selective immediate reactions to clavulanate accounted for over a third of cases with confirmed reactions after amoxicillin-clavulanate intake, with more than half experiencing anaphylaxis. Within this group, skin test sensitivity was below 50%. People taking amoxicillin-clavulanate may also be co-sensitized to both drugs.PMID:37021506 | DOI:10.4168/aair.2023.15.2.201
Source: Allergy, Asthma and Immunology Research - April 6, 2023 Category: Allergy & Immunology Authors: Isabel Torres-Rojas Diana P érez-Alzate Maria Luisa Somoza Ana Prieto-Moreno Pfeifer Elisa Haroun Diaz Teodorikez W Jimenez-Rodriguez Javier Fern ández Sánchez Francisco J Ruano Miguel Blanca Natalia Blanca-L ópez Source Type: research